KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Equity Ratio (2016 - 2026)

Medpace Holdings filings provide 12 years of Equity Ratio readings, the most recent being 0.28 for Q1 2026.

  • On a quarterly basis, Equity Ratio fell 10.2% to 0.28 in Q1 2026 year-over-year; TTM through Mar 2026 was 0.28, a 10.2% decrease, with the full-year FY2025 number at 0.23, down 40.86% from a year prior.
  • Equity Ratio hit 0.28 in Q1 2026 for Medpace Holdings, up from 0.23 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.45 in Q1 2022 to a low of 0.11 in Q2 2025.
  • Median Equity Ratio over the past 5 years was 0.29 (2022), compared with a mean of 0.3.
  • Biggest five-year swings in Equity Ratio: soared 50.3% in 2024 and later crashed 72.43% in 2025.
  • Medpace Holdings' Equity Ratio stood at 0.29 in 2022, then increased by 18.09% to 0.34 in 2023, then rose by 16.48% to 0.39 in 2024, then plummeted by 40.86% to 0.23 in 2025, then grew by 20.9% to 0.28 in 2026.
  • The last three reported values for Equity Ratio were 0.28 (Q1 2026), 0.23 (Q4 2025), and 0.17 (Q3 2025) per Business Quant data.